- RBI governor Shaktikanta Das believes that the country’s economy will grow in the 2nd quarter.
- The 60 MW NMHEP second unit has been successfully synchronized with the National Grid by SJVN.
- After continuing their upward trend, shares of the IREDA hit a new high of Rs 68.91.
In contrast to the 6.5% estimate made by the monetary policy committee, Reserve Bank of India governor Shaktikanta Das believes that the country’s economy will grow in the second quarter. Later today, the national account figures—including the GDP—are anticipated to be disclosed.
The 60 MW Naitwar Mori Hydro Electric Project (NMHEP) Second Unit has been successfully synchronized with the National Grid by SJVN, producing 265.5 million units of electricity per year.
Today’s stocks
In intraday trading, Trent’s market capitalization increased to Rs 98,399 crore, and the board of directors of the company decided to increase the market borrowing program for FY24 from Rs 1.2 trillion to Rs 1.5 trillion.
Amid the real estate market’s comeback in India, DLF Ltd. is considering selling bonds for the first time in three years. With China, the second-biggest economy in the world, slowing down and Western nations flirting with recession, India is viewed as a global bright spot.
Owing to better-than-expected Q2 results, robust growth in the food business, and margin gains in the beverage and international businesses, Tata Consumer Products’ stock has risen to new all-time highs. The majority of brokerages see growth potential in the stock and think that the stock’s high valuations are reasonable.
Because of the US Retirement Fund’s benchmark switch, Reliance Industries, ICICI Bank, Infosys, and HDFC Bank are anticipated to receive the largest inflows among domestic equities. After continuing their upward trend, shares of the Indian Renewable Energy Development Agency (IREDA) hit a new high of Rs 68.91.
The US FDA has given Eugia Pharma Specialities, a subsidiary of Aurobindo Pharma, final approval to produce and distribute Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampule, which is anticipated to go on sale in FY25.
